| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/28/2008 | CN101185727A Traditional Chinese medicine preparation containing ginseng and pilose antler capable of nourishing heart and nourishing kidney |
| 05/28/2008 | CN100390170C 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390143C Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
| 05/28/2008 | CN100389801C Insulin sensitivity enhancing medicinal composition |
| 05/27/2008 | US7378526 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 05/27/2008 | US7378522 Such as 6-(4-Acetamidophenoxy)-5-(N-benzyl-N-methylaminomethyl)-1-(2',6'-difluorobenzyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid-ethyl ester; rapid effectiveness, bioavailability; low cost, simple synthesis |
| 05/27/2008 | US7378488 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378406 11 beta -(4-acetylphenyl)-17 beta-hydroxy-17-alpha-(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one or a derivative, especially for prophylaxis and treatmenet of breast cancer |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378397 Peptide derivatives; thyrotropin-releasing hormone-degrading; brain and spinal injuries, central nervous system disorders |
| 05/27/2008 | US7378394 Sustained-release microparticle preparation of human growth hormone and process for producing thereof |
| 05/27/2008 | US7378077 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059854A1 Piperidine derivatives or salts thereof |
| 05/22/2008 | WO2008059267A1 Selective glycosidase inhibitors |
| 05/22/2008 | WO2008058767A1 Progesterone receptor antagonists |
| 05/22/2008 | WO2008058449A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058448A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2006005611A3 Glucocorticoid 16alpha,17.alpha.-isoxazolidines as anti-inflammatory agents |
| 05/22/2008 | US20080120734 Compositions and methods for regulated protein expression in gut |
| 05/22/2008 | US20080119528 use of specific cyklolignans |
| 05/22/2008 | US20080119516 2-'4(Phenylamino)-Piperidin-1-Yl!-N-Phenyl-Acetamine Derivatives and Related Compounds as Neuropeptide Y5 (NPY5) Ligands for the Treatment of Obesity |
| 05/22/2008 | US20080119514 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases |
| 05/22/2008 | US20080119504 aporphine 10- and 11-mono-esters and 10,11-asymmetric di-esters; dopaminergic agonist; Parkinson's disease, hemicrania, restless leg syndrome, sexual dysfunction, hyperprolactemia and psychotic disorders |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119455 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 05/22/2008 | US20080119454 Aryl carbonyl derivatives as therapeutic agents |
| 05/22/2008 | US20080119449 Reducing the risk of osteoporotic bone fractures; kit |
| 05/22/2008 | US20080119435 Hes6 as a marker of pancreatic endocrine cells |
| 05/22/2008 | US20080119402 Compositions and methods for the inhibition of dishevelled proteins |
| 05/22/2008 | CA2669767A1 Progesterone receptor antagonists |
| 05/22/2008 | CA2669635A1 Piperidine derivative or salt thereof |
| 05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2669357A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/21/2008 | EP1922303A2 Purification of paricalcitol |
| 05/21/2008 | EP1448591B1 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1265911B1 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/21/2008 | CN101184760A Heterocyclic spiro-compounds |
| 05/21/2008 | CN101184485A Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors |
| 05/21/2008 | CN101181236A Exendin agonist peptide formulations and administration method thereof |
| 05/21/2008 | CN101181195A Multifunctional shampoo |
| 05/21/2008 | CN100388916C Rate controlling membranes for controlled drug delivery device |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375109 Glycine-substituted thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity |
| 05/20/2008 | CA2589987C Method for treating a cholinergic influenced secretion |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2416976C Treatment of estrogen receptor positive carcinoma with a rapamycin and an antiestrogen |
| 05/20/2008 | CA2333668C 17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/20/2008 | CA2322862C 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/15/2008 | WO2008057282A1 Calcium receptor modulating agents |
| 05/15/2008 | WO2008055445A1 Method and composition for increasing insulin sensitivity |
| 05/15/2008 | US20080112887 Pancreatitis |
| 05/15/2008 | CA2672956A1 Calcium receptor modulating agents |
| 05/14/2008 | EP1921066A1 Pyridylphenol compound and use thereof |
| 05/14/2008 | EP1921065A1 Phenylpyridone derivative |
| 05/14/2008 | EP1919878A1 Pyridazinone derivatives as thyroid hormone receptor agonists |
| 05/14/2008 | EP1660184A4 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 05/14/2008 | EP1427748B1 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 05/14/2008 | EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/14/2008 | CN101180097A Novel phosphinic acid-containing thyromimetics |
| 05/14/2008 | CN101176787A Method for chemoprevention of prostate cancer |
| 05/14/2008 | CN101176786A Method and composition for increasing insulin sensibility |
| 05/14/2008 | CN101176781A Chinese medicine for curing children sexual precosity |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | CA2438169C Modulated release particles for aerosol delivery |
| 05/13/2008 | CA2310222C New composition of matter |
| 05/13/2008 | CA2184916C Use of fibroblast growth factors to stimulate bone growth |
| 05/13/2008 | CA2125855C A stabilized pharmaceutical formulation comprising growth hormone and histidine |
| 05/08/2008 | WO2008053909A1 Agent for controlling growth and/or differentiation of mesenchymal stem cell |
| 05/08/2008 | WO2008015099A3 Pegylated, extended insulins |
| 05/08/2008 | US20080108778 Lactic acid-glycolic acid polymer having ratio or weight average molecular weight and number average molecular weight of about 1.90 or lower, or a salt thereof, and a physiologically active substance; for treating prostate cancer, prostatomegaly, endometriosis, hysteromyoma, metrofibroma, breast cancer |
| 05/08/2008 | US20080108691 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly |
| 05/08/2008 | US20080108662 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 05/08/2008 | US20080108647 Treatment of HIV and diseases of immune dysregulation |
| 05/08/2008 | US20080108623 N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent |
| 05/08/2008 | US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 05/08/2008 | US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 05/08/2008 | US20080108590 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/08/2008 | US20080108571 folliculogenesis and follicular maturation without ovarian hyperstimulation; contain various FSH-to-hCG ratios and a carrier; enable the practitioner to optimize ovulatory stimulation in flexible manner |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/07/2008 | EP1917001A2 Pharmaceutical composition comprising a dpp-iv inhibitor |
| 05/07/2008 | EP1513588B1 Use of new etonogestrel esters |
| 05/07/2008 | EP1460969B1 Prevention and treatment of androgen-deprivation induced osteoporosis |
| 05/07/2008 | EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 05/07/2008 | EP1383774B1 Dihydroimidazo¬4,5-e indole and 7h-pyrrolo¬3,2-f quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 05/07/2008 | EP1372688B1 Somatostatin antagonists |
| 05/07/2008 | EP1137666B1 Glp-1 analogues |
| 05/07/2008 | CN101175747A Substituted N-arylpyrrolidines as selective androgen receptor modulators |
| 05/07/2008 | CN100386318C Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
| 05/07/2008 | CN100386314C Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof |
| 05/06/2008 | US7368436 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |